Literature DB >> 9870281

The "mini-perc" technique: a less invasive alternative to percutaneous nephrolithotomy.

S V Jackman1, S G Docimo, J A Cadeddu, J T Bishoff, L R Kavoussi, T W Jarrett.   

Abstract

The disadvantages of standard percutaneous nephrolithotomy (PCNL) as compared with ureteroscopy or extracorporeal shock-wave lithotripsy include increased blood loss, greater pain, and longer hospital stay. A 13-Fr "mini-perc" technique using a ureteroscopy sheath for PCNL was developed in an attempt to address these drawbacks. Nine "mini-percs" have been performed in patients aged 40-73 years with stone burdens of < or = 2 cm2. On average, patients had 1.4 stones with a cross-sectional area of 1.5 cm2. The mean total procedure time, estimated blood loss, and hematocrit decrease were 176 min, 83 ml, and 6.6%, respectively. On average, patients used 14 mg of parenteral morphine and stayed 1.7 days in the hospital. There was no procedure-related complication or transfusion. Eight of nine kidneys (89%) were stone-free on early follow-up at a mean of 3.8 weeks. As compared with standard PCNL, the "mini-perc" technique has similar early success rates in selected patients and may offer advantages with respect to hemorrhage, postoperative pain, and shortened hospital stays.

Entities:  

Mesh:

Year:  1998        PMID: 9870281     DOI: 10.1007/s003450050083

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  84 in total

Review 1.  The efficacy and safety of tubeless percutaneous nephrolithotomy: a systematic review and meta-analysis.

Authors:  Haichao Yuan; Shuo Zheng; Liangren Liu; Ping Han; Jia Wang; Qiang Wei
Journal:  Urol Res       Date:  2011-01-30

Review 2.  Appropriate kidney stone size for ureteroscopic lithotripsy: When to switch to a percutaneous approach.

Authors:  Ryoji Takazawa; Sachi Kitayama; Toshihiko Tsujii
Journal:  World J Nephrol       Date:  2015-02-06

3.  Is standard percutaneous nephrolithotomy still the standard treatment modality for renal stones less than three centimeters?

Authors:  Ömer Sarılar; Faruk Özgör; Onur Küçüktopçu; Burak Uçpınar; Mehmet Fatih Akbulut; Metin Savun; Zafer Gökhan Gürbüz; Murat Binbay
Journal:  Turk J Urol       Date:  2017-05-03

4.  A prospective comparative study of haemodynamic, electrolyte, and metabolic changes during percutaneous nephrolithotomy and minimally invasive percutaneous nephrolithotomy.

Authors:  Shuxiong Xu; Hua Shi; Jianguo Zhu; Yuanlin Wang; Ying Cao; Kai Li; Yandong Wang; Zhaolin Sun; Shujie Xia
Journal:  World J Urol       Date:  2013-11-01       Impact factor: 4.226

5.  Comparison of miniaturized percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for the treatment of large kidney stones: a randomized prospective study.

Authors:  Ali Güler; Akif Erbin; Burak Ucpinar; Metin Savun; Omer Sarilar; Mehmet Fatih Akbulut
Journal:  Urolithiasis       Date:  2018-06-01       Impact factor: 3.436

6.  Keyhole surgery of the kidney at sultan qaboos university hospital, oman.

Authors:  Mohammed S Al-Marhoon; Josephkunju Mathew; Hawraa Al-Lawati
Journal:  Sultan Qaboos Univ Med J       Date:  2007-08

Review 7.  The management of the access tract after percutaneous nephrolithotomy.

Authors:  Tanja Hüsch; Michael Reiter; René Mager; Eva Steiner; Thomas R W Herrmann; Axel Haferkamp; David Schilling
Journal:  World J Urol       Date:  2015-04-23       Impact factor: 4.226

8.  PCNL in the twenty-first century: role of Microperc, Miniperc, and Ultraminiperc.

Authors:  Arvind P Ganpule; Amit Satish Bhattu; Mahesh Desai
Journal:  World J Urol       Date:  2014-10-15       Impact factor: 4.226

9.  Nomenclature in PCNL or The Tower Of Babel: a proposal for a uniform terminology.

Authors:  David Schilling; Tanja Hüsch; Markus Bader; Thomas R Herrmann; Udo Nagele
Journal:  World J Urol       Date:  2015-02-12       Impact factor: 4.226

10.  Tubeless percutaneous nephrolithotomy.

Authors:  Madhu Sudan Agrawal; Mayank Agrawal
Journal:  Indian J Urol       Date:  2010 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.